E Fund Management Co., Ltd. Akebia Therapeutics, Inc. Transaction History

E Fund Management Co., Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.32 - $0.67 $11,280 - $23,617	-35,250 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$0.72 - $2.93 $7,814 - $31,799	10,853 Added 44.48%	35,250 $25,000
Q4 2021 Feb 11, 2022	SELL	$2.26 - $3.34 $28,760 - $42,504	-12,726 Reduced 34.28%	24,397 $55,000
Q3 2021 Nov 12, 2021	SELL	$2.35 - $3.88 $3,024 - $4,993	-1,287 Reduced 3.35%	37,123 $107,000
Q1 2021 May 12, 2021	BUY	$2.92 - $5.06 $112,157 - $194,354	38,410 New	38,410 $129,000

120

54.8M

291K

179K

Ticker AKBA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 183,848,992
Market Cap $359M
Description
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...

Get notified when there are updates to the investment portfolio of E Fund Management Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on E Fund Management Co., Ltd. with notifications on news.